News | Radiology Business | October 13, 2022

Key milestone in GE HealthCare’s journey to becoming standalone public company leading precision health innovation; marks continued progress on GE’s plans to form three companies 

Creating innovative leader in healthcare with a powerful global franchise enabling more precise, connected, and compassionate care

October 13, 2022 —   GE (NYSE:GE) today announced the filing of the Form 10 registration statement with the U.S. Securities and Exchange Commission (“SEC”) for the planned spin-off of its Healthcare division, to be called GE HealthCare

A copy of the Form 10 is available on the SEC website at www.sec.gov and can also be viewed on www.ge.com/investor-relations/sec-filings. Downloadable historical financial and pro forma financial information can also be accessed as an attachment to this press release as well as at https://www.ge.com/investor-relations/spinoff-resources

GE Chairman and CEO and GE Aerospace CEO H. Lawrence Culp, Jr., said, “GE HealthCare is an established leader in large, growing markets with a global franchise that is positioned to deliver patient, customer, and shareholder value. As a result of its planned spin-off, GE HealthCare will have greater focus and flexibility to serve its customers and invest in growth, and this filing is an important step on that journey.” 

GE HealthCare CEO Peter Arduini said, “This is a milestone day for the GE HealthCare team, who is dedicated to our mission to create a world where healthcare has no limits. We believe we have a clear path to deliver precision innovation for our customers and their patients while accelerating growth and optimizing our business as a standalone company.” 

Highlights from Form 10 

The Form 10 includes detailed information about GE HealthCare, including an overview of its business and strategy, historical financial information, and competitive advantages, among other details. Key information detailed in the Form 10 demonstrates how GE HealthCare expects to: 

  • Drive industry-leading precision innovation to deliver better outcomes for patients and customers, with significant opportunities driven by digitizing healthcare; connecting care across diagnostics, therapy, and monitoring; and serving across care pathways and sites of care. 
  • Accelerate growth through product leadership and commercial execution. Amid strong global and end-market dynamics, GE HealthCare intends to invest in innovation, pursue a disciplined capital allocation strategy, and enhance its commercial execution to drive sustainable growth. 
  • Optimize its operating model through a simplified, more decentralized structure—including tailoring its business model as a standalone leader in healthcare, leveraging lean principles, and continuing to foster its purpose-driven, action-oriented culture. 

GE HealthCare will be organized into four business segments aligned with the industries it serves: 

Imaging: solutions including CT, MRI, molecular imaging, X-ray, women’s health, image-guided therapies, enterprise imaging software, service capabilities, and digital solutions; 

  • Ultrasound: consoles and probes, handheld devices, intraoperative imaging systems, visualization software, service capabilities, and digital solutions; 
  • Patient Care Solutions: monitoring, anesthesia and respiratory care, maternal infant care, and diagnostic cardiology, as well as consumables, service capabilities, and digital solutions; and 
  • Pharmaceutical Diagnostics: imaging agents that include contrast media and radiopharmaceuticals that enhance diagnostic images. 

Additional Information 

As previously announced, GE plans to form three independent, investment grade, industry-leading companies focused on the critical growth sectors of aviation, healthcare, and energy. 

GE HealthCare will become a pure-play global healthcare leader following its planned spin-off, which GE continues to expect to complete in the first week of 2023 subject to final approval from the GE Board of Directors and other customary conditions. GE HealthCare will list on The Nasdaq Global Select Market under the ticker symbol “GEHC.” In September, GE announced GE HealthCare’s first Board of Directors, which will bring a strong mix of expertise, industry experience, and diverse perspectives to the company. 

As shared in November 2021, GE HealthCare plans to issue debt securities, the proceeds of which are expected to be used to pay down outstanding GE debt over time. 

The planned spin-off of GE HealthCare is intended to be tax-free for GE and GE shareholders for U.S. federal income tax purposes. To effect the separation, GE plans to distribute at least 80.1% of GE HealthCare’s common stock to GE’s shareholders. Shareholders do not need to take any action to receive the shares of GE HealthCare to which they will be entitled. GE expects to retain a stake of 19.9 percent in GE HealthCare. 

As previously announced, GE HealthCare will host an investor day on Thursday, December 8, 2022, in New York, NY. GE HealthCare’s management team will present its growth strategies and financial outlook, as well as a showcase of its innovative solutions. 

Investors, media, and the general public are invited to learn more about the pending spin-off at https://www.ge.com/investor-relations/spinoff-resources. Future updates to the Form 10 will be filed with the SEC and may be viewed at www.sec.gov as filings under GE HealthCare’s current name, GE Healthcare Holding LLC. The Form 10 filed on October 11, 2022, is subject to change and will be made final prior to the effective date. 

For more information: www.ge.com 

 

*GE’s existing energy portfolio of businesses, including Renewable Energy, Power, Digital, and Energy Financial Services, will sit together under the brand name GE Vernova. 


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Radiology Imaging

February 23, 2024 — The American Society of Radiologic Technologists (ASRT) launched its "Be Seen" campaign today to ...

Time February 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
arrow
News | Teleradiology

February 21, 2024 —Yellowcross Healthcare Commerce, a telemedicine practice management organization, launched a new ...

Time February 21, 2024
arrow
Subscribe Now